Introduction
Of the 40 therapeutic classes (across 14 therapeutic categories) that have examined Progression of Modern Therapeutics (last report issued in early 2016, under Reports) a more extended reporting has been made on a total of 16 therapeutic classes, under Posts. The majority of these posts involved the following subtitles: Background, Drug Approvals, Comments, and References (as appropriate), as exemplified by the post on Benign Prostatic Hyperplasia (BPH: Relying on Mechanisms First Approved a Quarter of a Century Ago, August 2016, click here), in addition to a timeline chart illustrating the individual approved drugs and their mechanisms of action.
Since these posts on individual therapeutic classes were only listed under their months of posting, the purpose of this reporting is to summarize 16 of these therapeutic classes under their therapeutic categories, including the titles of these posts.
Cardiovascular Therapeutics
Hypertension Progression of Modern Antihypertensive Therapeutics: An Example of a Mature Therapeutic Class. (December 2014) Click here.
Dyslipidemia Lipid Lowering Drugs: Steady Progress Over Half a Century. (September 2015) Click here.
Hematologic Therapeutics
Thrombosis Progression of Modern Antithrombotic Drugs: What’s Next? (January 2015) Click here.
Gastroenterologic Therapeutics
Acid Reflux and Ulcer Disease Progression of Acid Reflux and Ulcer Disease Therapeutics. (October 2014) Click here.
Irritable Bowel Syndrome IBS: Underlying Mechanism(s) Not Established but Six New Drug Approvals Since 2000. (September 2016) Click here.
Endocrinologic Therapeutics
Type-2 Diabetes Progression of Modern Therapeutics for Type-2 Diabetes. (November 2014) Click here.
Obesity Weight Reduction Drugs: Slow Progression and Innovation. (March 2015) Click here.
Osteoporosis Osteoporosis: Better Drugs and Better Scientific Understanding Needed. (July 2016) Click here.
Psychopharmacologic Therapeutics
Schizophrenia and Depression Slow Progress in Psychopharmacologic Therapeutics. (September 2014) Click here.
Attention Deficit Hyperactivity Disorder ADHD Therapeutics: Slow and Limited Progress. (November 2015) Click here.
Insomnia Modern Insomnia Therapeutics: Not the Barbiturates or Anxiolytic Benzodiazepines of Yore. (April 2016) Click here.
Neurologic Therapeutics
Alzheimer’s Disease Alzheimer’s Disease: Many Years to Go. (June 2015) Click here.
Migraine Migraine Therapeutics: Slow Progress Towards Precision Medicine. (December 2015) Click here.
Rheumatologic Therapeutics
Rheumatoid Arthritis Progression of Modern Therapeutics for Rheumatoid Arthritis. (October 2015) Click here.
Gout and Hyperuricemia Gout and Hyperuricemia: Reliance on Old Mechanisms. (March 2016) Click here.
Genitourinary Therapeutics
Benign Prostatic Hyperplasia BPH: Relying on Mechanisms First Approved a Quarter of a Century Ago. (August 2016) Click here.